Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durrieu, G.
Right arrow Articles by Montastruc, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durrieu, G.
Right arrow Articles by Montastruc, J. L.
NEUROLOGY 1990;40:707
© 1990 American Academy of Neurology

Blood pressure and plasma catecholamines in never-treated parkinsonian patients

Effect of a selective D1 agonist (CY 208-243)

G. Durrieu, BS, J. M. Senard, MD, O. Rascol, MD, M. A. Tran, PhD, X. Lataste, MD, PhD, A. Rascol, MD and J. L. Montastruc, MD, PhD

Laboratoire de Pharmacologie Médicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculté de Médecine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association "France-Parkinson."

We found blood pressure (BP), heart rate (HR), plasma norepinephrine (NE), and epinephrine (E) levels in the lying and the standing positions to be similar in never-treated parkinsonian patients (stages 1 and 2) and age-matched controls. CY 208-243, a new centrally active D1 agonist, significantly decreased BP, HR, and NE (but not E) values in the lying position; it elicited orthostatic hypotension and blunted the rise in NE elicited by standing up. These results indicate that the early stages of Parkinson's disease are not accompanied by major changes in autonomie cardiovascular function and suggest the involvement of central D1-receptors in the control of sympathetic tone.

Address correspondence and reprint requests to Prof. Jean-Louis Montastruc, Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine, 37 allées Jules Guesde, 31073 Toulouse Cedex, France.

Received June 20, 1989. Accepted for publication in final form September 21, 1989.




This article has been cited by other articles:


Home page
NeurologyHome page
D. S. Goldstein, C. S. Holmes, R. Dendi, S. R. Bruce, and S.-T. Li
Orthostatic hypotension from sympathetic denervation in Parkinson's disease
Neurology, April 23, 2002; 58(8): 1247 - 1255.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.